Display options
Cite
Camilli M, Lombardi M, Chiabrando JG, et al. Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: an updated meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2021;7(4):e74-e76doi: 10.1093/ehjcvp/pvab034.
Camilli, M., Lombardi, M., Chiabrando, J. G., Del Buono, M. G., Montone, R. A., Biondi-Zoccai, G., Crea, F., & Minotti, G. (2021). Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: an updated meta-analysis. European heart journal. Cardiovascular pharmacotherapy, 7(4), e74-e76. https://doi.org/10.1093/ehjcvp/pvab034
Camilli, Massimiliano, et al. "Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: an updated meta-analysis." European heart journal. Cardiovascular pharmacotherapy vol. 7,4 (2021): e74-e76. doi: https://doi.org/10.1093/ehjcvp/pvab034
Camilli M, Lombardi M, Chiabrando JG, Del Buono MG, Montone RA, Biondi-Zoccai G, Crea F, Minotti G. Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: an updated meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):e74-e76. doi: 10.1093/ehjcvp/pvab034. PMID: 33930138.
Copy Download .nbib Format: NLM
Share it on

Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):e74-e76. doi: 10.1093/ehjcvp/pvab034.

Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: an updated meta-analysis.

European heart journal. Cardiovascular pharmacotherapy

Massimiliano Camilli, Marco Lombardi, Juan Guido Chiabrando, Marco Giuseppe Del Buono, Rocco Antonio Montone, Giuseppe Biondi-Zoccai, Filippo Crea, Giorgio Minotti

Affiliations

  1. Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, L.go Francesco Vito, 1. Rome, 00168, Italy.
  2. Department of Interventional Cardiology, Hospital Italiano de Buenos Aires, Pres. Tte. Gral. Juan Domingo Perón. Buenos Aires, Argentina.
  3. Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A.Gemelli. Rome, 00168, Italy.
  4. Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome. Latina, 04100, Italy.
  5. Mediterranea-Cardiocentro, Via Ponte di Tappia. Napoli, 80133, Italy.
  6. Department of Medicine, Center for Integrated Research and Unit of Drug Sciences, University Campus Bio-Medico, Via Alvaro Del Portillo 21, 00168 Rome, Italy.

PMID: 33930138 DOI: 10.1093/ehjcvp/pvab034

[No abstract available.]

Publication Types